TrpC5 regulates differentiation through the Ca2+/Wnt5a signalling pathway in colorectal cancer

Clin Sci (Lond). 2017 Feb 1;131(3):227-237. doi: 10.1042/CS20160759. Epub 2016 Nov 28.

Abstract

Transient receptor potential channel 5 (TrpC5) is a member of the TrpC subgroup, and it forms a receptor-activated, non-selective Ca2+ channel. The architecture of the TrpC5 channel is poorly understood. In the present study, we report that TrpC5 is a key factor in regulating differentiation in colorectal cancer (CRC). Through a study of specimens from a large cohort of patients with CRC, we found that TrpC5 was highly expressed and its cellular level correlated with tumour grade. We showed further that up-regulated TrpC5 caused a robust rise in intracellular calcium concentration [Ca2+]i, increased Wnt5a expression and the nuclear translocation of β-catenin, leading to a reduction in cancer differentiation and an increase in cancer cell stemness. Notably, patients with tumours that expressed high levels of TrpC5 showed significantly poorer disease-free and overall survival. Therefore, our findings suggest that TrpC5 is an independent adverse prognostic factor for death in CRC, reducing differentiation through the Ca2+/Wnt5a signalling pathway.

Keywords: Ca2+/Wnt5a signalling pathway; TrpC5 ion channel; cancer cell differentiation; colorectal cancer.

MeSH terms

  • Animals
  • Caco-2 Cells
  • Calcium Signaling*
  • Carcinoma / diagnosis
  • Carcinoma / metabolism*
  • Carcinoma / pathology
  • Cell Differentiation
  • Colorectal Neoplasms / diagnosis
  • Colorectal Neoplasms / metabolism*
  • Colorectal Neoplasms / pathology
  • HT29 Cells
  • Humans
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neoplasm Grading
  • Prognosis
  • TRPC Cation Channels / metabolism*
  • Wnt-5a Protein / metabolism*
  • beta Catenin / metabolism

Substances

  • TRPC Cation Channels
  • TRPC5 protein, human
  • WNT5A protein, human
  • Wnt-5a Protein
  • beta Catenin